by Tim Daly | Apr 19, 2022 | AI, Anouncement, Regulatory Certification
Achieving UKCA Class IIa certification for our DERM skin lesion analysis device is not just an important milestone in our company’s growth; it’s validation of the incredible work that our team has produced over the years. Whether it be artificial intelligence...
by Tim Daly | Nov 16, 2021 | AI, Research, Skin Cancer, Uncategorized
We were delighted to see research into the publicly available skin cancer datasets many use to train AI systems to assess skin cancer published in The Lancet Digital Health last week. Applying academic rigour to a long known issue around machine learning helps to...
by Tim Daly | Jul 14, 2021 | AI, Anouncement
Deployment of unique diagnosis aid to be boosted across the NHS Currently deployed in University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, AI platform DERM will now be available to clinicians serving millions of patients around the...
by Tim Daly | Jun 3, 2021 | AI, Anouncement
Google’s announcement of the culmination of three years of work and a subsequent move into skin disease analysis at their developer conference earlier this week has led to a number of people approaching me to ask what does this mean for Skin Analytics? Spoiler alert:...
by Tim Daly | Feb 13, 2020 | AI, Anouncement, Blog, Research
In February 2020, skin cancer researchers released a paper calling into question the quality of evidence behind the current crop of consumer-facing skin cancer apps. Given that we’re focused on the integration of our AI into health providers like the NHS and Vitality...
